Sanofi India Limited [SANOFI] vs Sanofi Consumer [SANOFICONR] Detailed Stock Comparison

Sanofi India Limited
NSE
Loading...

Sanofi Consumer
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sanofi India Limited wins in 9 metrics, Sanofi Consumer wins in 10 metrics, with 0 ties. Sanofi Consumer appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Sanofi India Limited | Sanofi Consumer | Better |
---|---|---|---|
P/E Ratio (TTM) | 33.00 | 59.51 | Sanofi India Limited |
Price-to-Book Ratio | 15.31 | 46.41 | Sanofi India Limited |
Debt-to-Equity Ratio | 2.67 | 11.01 | Sanofi India Limited |
PEG Ratio | 25.52 | 6.10 | Sanofi Consumer |
EV/EBITDA | 23.40 | 45.67 | Sanofi India Limited |
Profit Margin (TTM) | 18.29% | 27.62% | Sanofi Consumer |
Operating Margin (TTM) | 21.12% | 30.42% | Sanofi Consumer |
EBITDA Margin (TTM) | 21.12% | 30.42% | Sanofi Consumer |
Return on Equity | 49.43% | 66.30% | Sanofi Consumer |
Return on Assets (TTM) | 22.47% | 41.97% | Sanofi Consumer |
Free Cash Flow (TTM) | $4.25B | $4.29B | Sanofi Consumer |
Dividend Yield | 1.93% | 1.08% | Sanofi India Limited |
1-Year Return | -23.97% | 5.78% | Sanofi Consumer |
Price-to-Sales Ratio (TTM) | 6.05 | 16.51 | Sanofi India Limited |
Enterprise Value | $116.82B | $117.41B | Sanofi Consumer |
EV/Revenue Ratio | 5.90 | 16.22 | Sanofi India Limited |
Gross Profit Margin (TTM) | 48.63% | 72.30% | Sanofi Consumer |
Revenue per Share (TTM) | $860 | $314 | Sanofi India Limited |
Earnings per Share (Diluted) | $157.54 | $87.04 | Sanofi India Limited |
Beta (Stock Volatility) | 0.08 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sanofi India Limited vs Sanofi Consumer Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Sanofi India Limited | -0.62% | -5.91% | -14.06% | -12.99% | -5.04% | -16.33% |
Sanofi Consumer | -0.76% | -3.02% | -0.30% | 4.63% | 8.62% | 4.55% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Sanofi India Limited | -23.97% | -19.35% | -41.99% | 24.21% | 178.13% | 255.65% |
Sanofi Consumer | 5.78% | 5.78% | 5.78% | 5.78% | 5.78% | 5.78% |
Performance & Financial Health Analysis: Sanofi India Limited vs Sanofi Consumer
Metric | SANOFI | SANOFICONR |
---|---|---|
Market Information | ||
Market Cap | ₹119.89B | ₹119.55B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 12,818 | 28,486 |
90 Day Avg. Volume | 11,262 | 18,526 |
Last Close | ₹5,061.50 | ₹5,092.80 |
52 Week Range | ₹4,902.00 - ₹7,600.00 | ₹4,211.55 - ₹5,894.50 |
% from 52W High | -33.40% | -13.60% |
All-Time High | ₹10,524.95 (Jun 10, 2024) | ₹5,894.50 (Jun 30, 2025) |
% from All-Time High | -51.91% | -13.60% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.12% | 0.34% |
Quarterly Earnings Growth | -0.33% | 1.09% |
Financial Health | ||
Profit Margin (TTM) | 0.18% | 0.28% |
Operating Margin (TTM) | 0.21% | 0.30% |
Return on Equity (TTM) | 0.49% | 0.66% |
Debt to Equity (MRQ) | 2.67 | 11.01 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹339.62 | ₹111.61 |
Cash per Share (MRQ) | ₹135.75 | ₹94.19 |
Operating Cash Flow (TTM) | ₹3.90B | ₹2.25B |
Levered Free Cash Flow (TTM) | ₹2.49B | ₹1.81B |
Dividends | ||
Last 12-Month Dividend Yield | 1.93% | 1.08% |
Last 12-Month Dividend | ₹117.00 | ₹55.00 |
Valuation & Enterprise Metrics Analysis: Sanofi India Limited vs Sanofi Consumer
Metric | SANOFI | SANOFICONR |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 33.00 | 59.51 |
Forward P/E | 25.52 | 43.08 |
PEG Ratio | 25.52 | 6.10 |
Price to Sales (TTM) | 6.05 | 16.51 |
Price to Book (MRQ) | 15.31 | 46.41 |
Market Capitalization | ||
Market Capitalization | ₹119.89B | ₹119.55B |
Enterprise Value | ₹116.82B | ₹117.41B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.90 | 16.22 |
Enterprise to EBITDA | 23.40 | 45.67 |
Risk & Other Metrics | ||
Beta | 0.08 | N/A |
Book Value per Share (MRQ) | ₹339.62 | ₹111.61 |
Financial Statements Comparison: Sanofi India Limited vs Sanofi Consumer
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SANOFI | SANOFICONR |
---|---|---|
Revenue/Sales | ₹5.36B | ₹1.73B |
Cost of Goods Sold | ₹2.41B | ₹388.00M |
Gross Profit | ₹2.95B | ₹1.34B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹1.62B | ₹620.00M |
EBITDA | ₹1.75B | ₹692.00M |
Pre-Tax Income | ₹1.65B | ₹668.00M |
Income Tax | ₹458.00M | ₹168.00M |
Net Income (Profit) | ₹1.20B | ₹500.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SANOFI | SANOFICONR |
---|---|---|
Cash & Equivalents | ₹2.84B | ₹3.27B |
Total Current Assets | ₹11.27B | ₹3.92B |
Total Current Liabilities | ₹7.19B | ₹1.31B |
Long-Term Debt | ₹140.00M | ₹166.00M |
Total Shareholders Equity | ₹8.61B | ₹2.73B |
Retained Earnings | ₹4.46B | N/A |
Property, Plant & Equipment | ₹3.11B | ₹272.00M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SANOFI | SANOFICONR |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | SANOFI | SANOFICONR |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 12,818 | 28,486 |
Average Daily Volume (90 Day) | 11,262 | 18,526 |
Shares Outstanding | 23.03M | 23.03M |
Float Shares | 9.07M | 6.57M |
% Held by Insiders | 0.61% | 0.71% |
% Held by Institutions | 0.26% | 0.25% |
Dividend Analysis & Yield Comparison: Sanofi India Limited vs Sanofi Consumer
Metric | SANOFI | SANOFICONR |
---|---|---|
Last 12-Month Dividend | ₹117.00 | ₹55.00 |
Last 12-Month Dividend Yield | 1.93% | 1.08% |
3-Year Avg Annual Dividend | ₹220.00 | ₹18.33 |
3-Year Avg Dividend Yield | 2.07% | 1.11% |
3-Year Total Dividends | ₹660.00 | ₹55.00 |
Ex-Dividend Date | Apr 25, 2025 | Apr 17, 2025 |